Skip to main content

Advertisement

SpringerLink
Log in

IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status

  • Rapid Communication
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to evaluate the expression of IMP3, an independent poor prognostic factor for many cancers, and its association with clinicopathological features and HER2 status.

Methods

Gastrectomy specimens from 106 patients were evaluated by immunohistochemistry and fluorescence in situ hybridization.

Results

HER2 overexpression was found in 4.71 % of the samples. A negative association was observed between HER2 overexpression and grade of differentiation. No association was observed between HER2 overexpression and status of surgical margins, vascular invasion, perineural invasion, nodal metastasis and depth of invasion. Among all specimens of gastric cancer, 67.92 % were positive for IMP3. Expression of IMP3 was significantly higher in specimens with vascular invasion, perineural invasion, nodal metastasis and higher depth of invasion. HER2 overexpression was detected in only 5.55 % of IMP3 positive specimens.

Conclusions

IMP3 expression was frequently observed in gastric cancer and was associated with poor prognostic clinicopathological features. A survival benefit with HER2 therapy should be expected for the minority of patients with IMP3 positive specimens. Studies should be conducted to evaluate the response to HER2 therapy of gastric cancer expressing IMP3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • Bang YJ (2012) Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer. J Clin Gastroenterol 46(8):637–648

    Article  CAS  PubMed  Google Scholar 

  • Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

    Article  CAS  PubMed  Google Scholar 

  • Beljan Perak R, Durdov MG, Capkun V, Ivcevic V, Pavlovic A, Soljic V, Peric M (2012) IMP3 can predict aggressive behaviour of lung adenocarcinoma. Diagn Pathol 7(1):165

    Article  PubMed Central  PubMed  Google Scholar 

  • Bell JL, Wächter K, Mühleck B et al (2013) Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 70(15):2657–2675

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Boku N (2014) HER2-positive gastric cancer. Gastric Cancer 17:1–12

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brasil. Ministério da Saúde, Instituto Nacional de Câncer (2011) Estimativa 2012: incidência de câncer no Brasil/Instituto Nacional de Câncer. INCA, Rio de Janeiro

    Google Scholar 

  • Chua TC, Merrett ND (2012) Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes—a systematic review. Int J Cancer 130(12):2845–2856

    Article  CAS  PubMed  Google Scholar 

  • Clauditz TS, Wang CJ, Gontarewicz A, Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow C, Knecht R, Münscher A, Wilczak W (2013) Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck. J Oral Pathol Med 42(2):125–132

    Article  CAS  PubMed  Google Scholar 

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  CAS  PubMed  Google Scholar 

  • Gong Y, Woda BA, Jiang Z (2014) Oncofetal protein IMP3, a new cancer biomarker. Adv Anat Pathol 21(3):191–200

    Article  CAS  PubMed  Google Scholar 

  • Grabsch H, Sivakumar S, Gray S et al (2010) HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value—conclusions from 924 cases of two independent series. Cell Oncol 32:57–65

    PubMed  Google Scholar 

  • Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19:1523–1529

    Article  CAS  PubMed  Google Scholar 

  • Hechtman JF, Polydorides AD (2012) HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications. Arch Pathol Lab Med 136(6):691–697

    Article  PubMed  Google Scholar 

  • Hofmann M, Stoss O, Shi D et al (2008) Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 52:797–805

    Article  CAS  PubMed  Google Scholar 

  • Hu S, Wu X, Zhou B, Xu Z, Qin J, Lu H, Lv L, Gao Y, Deng L, Yin J, Li G (2014) IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 140(6):883–893

    Article  CAS  PubMed  Google Scholar 

  • Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, Rock KL, Wu CL (2008) Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Clin Cancer Res 14(17):5579–5584

    Article  CAS  PubMed  Google Scholar 

  • Jung JE, Ioshi SO (2013) Immunohistochemical assessment of HER2 expression in gastric cancer in a cohort of 118 Brazilian patients. J Bras Patol Med Lab 49:361–367

    Article  Google Scholar 

  • Li S, Cha J, Kim J, Kim KY, Kim HJ, Nam W, Cha IH (2011) Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma. Head Neck 33(3):368–374

    PubMed  Google Scholar 

  • Liao B, Hu Y, Brewer G (2011) RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem 286(36):31145–31152

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lin L, Zhang J, Wang Y, Ju W, Ma Y, Li L, Chen L (2013) Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma. Oncol Lett 6(3):740–744

    PubMed Central  PubMed  Google Scholar 

  • Maresch J, Schoppmann SF, Thallinger CM, Zielinski CC, Hejna M (2012) Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment. Crit Rev Oncol Hematol 82(3):310–322

    Article  PubMed  Google Scholar 

  • Okada K, Fujiwara Y, Nakamura Y et al (2012) Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma. J Surg Oncol 105(8):780–785

    Article  CAS  PubMed  Google Scholar 

  • Pryor JG, Bourne PA, Yang Q, Spaulding BO, Scott GA, Xu H (2008) IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol 21(4):431–437

    Article  CAS  PubMed  Google Scholar 

  • Rivera Vargas T, Boudoukha S, Simon A, Souidi M, Cuvellier S, Pinna G, Polesskaya A (2014) Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization. Oncogene 33(22):2866–2875

    Article  CAS  PubMed  Google Scholar 

  • Rüschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G (2012) HER2 testing in gastric cancer: a practical approach. Mod Pathol 25(5):637–650

    Article  PubMed  Google Scholar 

  • Samanta S, Pursell B, Mercurio AM (2013) IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression. J Biol Chem 288(18):12569–12573

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schaeffer DF, Owen DR, Lim HJ, Buczkowski AK, Chung SW, Scudamore CH, Huntsman DG, Ng SS, Owen DA (2010) Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer 10:59

    Article  PubMed Central  PubMed  Google Scholar 

  • Slamon DJ, Clark GM, Wong SG et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182

    Article  CAS  PubMed  Google Scholar 

  • Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783–792

    Article  CAS  PubMed  Google Scholar 

  • Walter O, Prasad M, Lu S et al (2009) IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Hum Pathol 40(11):1528–1533

    Article  CAS  PubMed  Google Scholar 

  • Wang L, Li HG, Xia ZS, Lü J, Peng TS (2010) IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study. Chin Med J (Engl) 123(24):3554–3558

    CAS  Google Scholar 

  • Won JR, Gao D, Chow C et al (2013) A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard. Mod Pathol 26(11):1438–1450

    Article  CAS  PubMed  Google Scholar 

  • Xylinas E, Cha EK, Khani F, Kluth LA, Rieken M, Volkmer BG, Hautmann R, Küfer R, Chen YT, Zerbib M, Rubin MA, Scherr DS, Shariat SF, Robinson BD (2014) Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. J Urol 191(3):830–841

    Article  CAS  PubMed  Google Scholar 

  • Zilberstein B, Malheiros C, Lourenço LG et al (2013) Brazilian consensus in gastric cancer: guidelines for gastric cancer in ABCD. Arq Bras Cir Dig 26(1):2–6

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Pathological Anatomy Center, University Hospital of Brasilia (UNB), Via L2 Norte, SGAN 604/605, Brasília, DF, CEP 70840-050, Brazil

    Emanuel Adelino M. Damasceno, Fabiana Pirani Carneiro, Albino Verçosa de Magalhães, Gustavo Henrique Soares Takano & Leonora Maciel de Sousa Vianna

  2. Pathology Department, Brasília University, Brasília, DF, Brazil

    Heinrich Bender Kohnert Seidler, Tercia Maria Mendes Lousa de Castro, Maria Imaculada Muniz-Junqueira, Rivadávio Fernandes Batista Amorim, Vânia Maria Moraes Ferreira & Andrea Barreto Motoyama

  3. Gastroenterology Service, Armed Forces Hospital of Brasilia, Brasília, DF, Brazil

    Marcos de Vasconcelos Carneiro

Authors
  1. Emanuel Adelino M. Damasceno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabiana Pirani Carneiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albino Verçosa de Magalhães
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcos de Vasconcelos Carneiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gustavo Henrique Soares Takano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leonora Maciel de Sousa Vianna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heinrich Bender Kohnert Seidler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tercia Maria Mendes Lousa de Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maria Imaculada Muniz-Junqueira
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rivadávio Fernandes Batista Amorim
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Vânia Maria Moraes Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Andrea Barreto Motoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabiana Pirani Carneiro.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Damasceno, E.A.M., Carneiro, F.P., de Magalhães, A.V. et al. IMP3 expression in gastric cancer: association with clinicopathological features and HER2 status. J Cancer Res Clin Oncol 140, 2163–2168 (2014). https://doi.org/10.1007/s00432-014-1850-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-014-1850-9

Keywords

Search

Navigation